(S)-4-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-((R)-2-((S)-2-((2S,5S,8R,15R)-15-(6-hydrazineylnicotinamido)-5-(4-hydroxybenzyl)-2-methyl-3,6,14,18-tetraoxo-1,4,7,13-tetraazacyclooctadecane-8-carboxamido)-3-(1H-indol-3-yl)propanamido)heptanamido)-4-oxobutanoic acid

ID: ALA5288951

Chembl Id: CHEMBL5288951

Max Phase: Preclinical

Molecular Formula: C60H76N14O13

Molecular Weight: 1201.35

Names and Identifiers

Canonical SMILES:  CCCCC[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H]1CCCCNC(=O)[C@H](NC(=O)c2ccc(NN)nc2)CCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C60H76N14O13/c1-3-4-6-17-42(57(84)73-48(31-51(77)78)60(87)70-45(52(61)79)28-35-13-7-5-8-14-35)69-59(86)47(30-38-33-64-41-16-10-9-15-40(38)41)72-56(83)43-18-11-12-27-63-55(82)44(67-54(81)37-21-25-49(74-62)65-32-37)24-26-50(76)66-34(2)53(80)71-46(58(85)68-43)29-36-19-22-39(75)23-20-36/h5,7-10,13-16,19-23,25,32-34,42-48,64,75H,3-4,6,11-12,17-18,24,26-31,62H2,1-2H3,(H2,61,79)(H,63,82)(H,65,74)(H,66,76)(H,67,81)(H,68,85)(H,69,86)(H,70,87)(H,71,80)(H,72,83)(H,73,84)(H,77,78)/t34-,42+,43+,44+,45-,46-,47-,48-/m0/s1

Standard InChI Key:  CAWKIUQLKQSRMD-GYFGTUTMSA-N

Alternative Forms

1. Parent:

   

   ALA5288951

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1201.35

Molecular Weight (Monoisotopic): 1200.5716

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Askari Rizvi SF, Zhang H..  (2021)  Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities.,  221  [PMID:34022717] [10.1016/j.ejmech.2021.113538]

Source

Source(1):

• Scientific Literature